Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 768 of 1,261
  1. US 8956601

    Therapeutic uses of mastic gum fractions

    REGENERA PHARMA LTD. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted
  2. US 8957097

    Hemi-phorboxazole A derivatives and methods of their use

    The Regents of the University of California · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted
  3. US 8956828

    Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

    Sangamo Biosciences, Inc. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted
  4. US 8957047

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted
  5. US 8956864

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted
  6. US 8952185

    Production method of optically active dihydrobenzofuran derivative

    Takeda Pharmaceutical Company Limited · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  7. US 8952062

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  8. US 8951972

    FGFR1 extracellular domain combination therapies for lung cancer

    Five Prime Therapeutics, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  9. US 8951793

    Method of making an isolated population of FOXP3+ regulatory T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  10. US 8951998

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  11. US 8952153

    One pot process for preparing pemetrexed disodium

    Kocak Farma Ilac ve Kimya Sanayi A.S. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  12. US 8952031

    Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  13. US 8951971

    Lymphatic zip codes in tumors and pre-malignant lesions

    The Regents of the University of California · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  14. US 8952161

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  15. US 8952029

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals Ireland Limited · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  16. US 8952032

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  17. US 8952025

    Multifunctional radical quenchers and their uses

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  18. US 8951964

    Phenanthridine macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  19. US 8951794

    Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

    The Regents of the University of California · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  20. US 8951968

    Methods of treating depression and other related diseases

    Northwestern University · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  21. US 8951551

    Multiribbon nanocellulose as a matrix for wound healing

    The Board of Regents of the University of Texas System · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  22. US 8951527

    Radioprotectants targeting thrombospondin-1 and CD47

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  23. US 8951754

    Methods and materials for making simvastatin and related compounds

    The Regents of the University of California · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  24. US 8951503

    Optical determination of glucose utilizing boronic acid adducts

    The Regents of the University of California · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.